Big tech companies spend 100% of cash flow on AI infrastructure, raising concerns about sustainability and market volatility ...

Revenue -- $42.4 million for the quarter, representing a 14.3% decrease year over year, mainly attributed to fewer orders ...

Both companies have seen their shares pull back this year, but one offers a significantly more attractive entry point for ...

C4 Therapeutics delivered strong 4Q25 results, with revenue up 111.5% YoY and operating expenses tightly controlled. Click for my latest analysis of CCCC stock.

The U.S. Postal Service will run out of cash within a year unless Congress lifts a decades-old cap and allows the agency to ...

Oklo isn't generating any revenue yet, but investors have been bullish on its future growth prospects.

Good afternoon, everyone, and thank you for joining us on today's call to discuss Gevo, Inc.'s fourth quarter and full year ...

The story of Arsenal’s past half-decade has been one of recovery and rejuvenation, a return to strength and challenging once more after years in the competitive wilderness. As o ...

Consolidated Revenue -- $7.1 million, a 7% decrease compared to the prior-year period, attributed primarily to reduced revenue at STADCO. STADCO Segment Performance -- Revenue of $2.9 million and ...

Good afternoon, everyone, and thank you for joining us on today's call to discuss Gevo's Fourth Quarter and Full year 2025 results. I'm Eric Frey, Vice President of Finance and Strategy at Gevo. With ...